KardiaPro

by AliveCor  · Based in United States → — Your Partner in Efficient Patient Monitoring and Analysis
Cardiology Family Medicine Internal Medicine
Website
Claim this tool
Is this the maker? Claim the company →

Contact for pricing
Regulatory Status Disclosed

Overview

KardiaPro is a comprehensive web-based portal designed for healthcare professionals to remotely monitor patient ECG, blood pressure, and weight data. It provides a secure platform to manage and review patient data between appointments, making it easier to analyze trends and make informed clinical decisions. The platform integrates seamlessly with AliveCor’s FDA-cleared Kardia™ devices, such as KardiaMobile and KardiaMobile 6L, centralizing patient data for clinical review and trend analysis. KardiaPro enhances clinical efficiency by enabling providers to receive, triage, and interpret cardiac recordings outside of traditional in-office settings, while maintaining regulatory compliance and supporting reimbursements under applicable CPT® codes. It helps clinicians detect arrhythmias, track longitudinal cardiac patterns, and manage large volumes of remote patient data securely from any internet-enabled workstation.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Comprehensive web-based portal for remote monitoring
  • ECG, blood pressure, and weight data management
  • FDA-cleared AI for arrhythmia detection
  • Customizable ECG inbox for efficient data review
  • Automated summary reports and trend visualization
  • Seamless integration with KardiaMobile and KardiaMobile 6L devices
  • Integration with KardiaStation for point-of-care solutions
  • HIPAA-compliant and SOC-2 certified data handling
  • Reimbursable using existing CPTu00ae codes
  • QT measurement capability (with 6-lead device)

Use Cases

  • Remote monitoring of cardiac patients
  • Early detection of arrhythmias like atrial fibrillation
  • Tracking longitudinal cardiac patterns
  • Managing chronic cardiovascular diseases
  • Streamlining in-office and remote patient data management
  • Supporting clinical decisions with real-time patient data

What Physicians Need to Know

ECG/EKG Analysis Capability
KardiaPro is a web-based portal for remote monitoring and analysis of ECG data captured by AliveCor's FDA-cleared KardiaMobile devices (single-lead and 6-lead). It provides instant analysis for detecting various arrhythmias and normal sinus rhythm. The platform allows customization of the ECG inbox to prioritize abnormal recordings and generates summary reports for trend identification. KardiaMobile 6L can also measure QT intervals and calculate QTc.
Arrhythmia Detection Accuracy
Kardia's AI algorithms, including 'Advanced Determinations,' are FDA-cleared and clinically validated for detecting Atrial Fibrillation (AFib), Bradycardia, Tachycardia, Sinus Rhythm with Premature Ventricular Contractions (PVCs), Sinus Rhythm with Supraventricular Ectopy (SVE), and Sinus Rhythm with Wide QRS. Studies have shown high sensitivity (95.3-100%) and specificity (94-98.7%) for AF detection compared to expert cardiology over-read of 12-lead EKGs.
Heart Failure Risk Prediction
While KardiaPro primarily focuses on arrhythmia detection and ECG monitoring, AliveCor (the company behind KardiaPro) is involved in transforming cardiology through AI-driven insights. General AI predictive modeling for CVD risk can combine medical history, demographics, labs, imaging, and lifestyle data to deliver actionable cardiovascular risk predictions and intervention planning. Risk prediction models for heart failure exist, utilizing various clinical factors.
Cardiac Monitoring Integration
KardiaPro integrates seamlessly with AliveCor's KardiaMobile (single-lead and 6-lead) and KardiaMobile Card devices for remote patient monitoring. It also functions as a point-of-care solution when paired with KardiaStation. The platform supports EHR/third-party interoperability through SDK/API configurations, allowing for the automatic pulling of ECGs into EHR systems like Epic, Cerner, and athenahealth. KardiaPro can also integrate data from Omron blood pressure devices and Apple Health.
Real-Time Alert Capability
KardiaPro allows physicians to access patient ECG recordings immediately after they are captured. The customizable ECG inbox can prioritize abnormal recordings, enabling clinicians to quickly review and act on urgent cardiac data. Real-time analysis and alerts are provided for KardiaMobile 6L when prescribed and used with a connected smartphone.
Physician Tip

Leverage KardiaPro's customizable ECG inbox to efficiently triage and review abnormal recordings, focusing your attention where it's most needed. Utilize the summary reports and trend visualizations for longitudinal patient reviews and informed clinical decision-making. Encourage patients to consistently use their KardiaMobile devices for comprehensive remote monitoring, which can significantly reduce the need for in-office ECGs and traditional long-term monitors, especially for AFib management. The QT measurement capability with KardiaMobile 6L can be valuable for managing patients on QT-prolonging medications.

KardiaPro offers robust integration capabilities through its API and SDK, facilitating seamless data flow with Electronic Health Record (EHR) systems such as Epic, Cerner, and athenahealth. This allows for automated transfer of patient ECG, blood pressure, and weight data, streamlining workflows and supporting reimbursable billing under existing CPT codes. The platform also integrates with Omron blood pressure devices and Apple Health for a more comprehensive patient data overview.

Details

Category Cardiology AI, Clinical Decision Support & Reference, Wearables & Remote Monitoring (RPM)
Pricing Contact for pricing
DeploymentCloud-hosted, Web-based
Compliance
BAA Available Yes AI-estimated
HIPAA Compliant Yes AI-estimated
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Cardiology, Family Medicine, Internal Medicine

What the Web Says

KardiaPro is generally well-regarded by physicians and healthcare professionals for its ability to provide remote patient monitoring for cardiovascular health. It integrates personal ECG devices with a clinician platform, allowing for efficient review of patient data and potential early detection of arrhythmias. While praised for its ease of use and data accessibility, some concerns exist regarding its cost and the potential for data overload for clinicians.

Overall: Positive

Strengths

  • Enables effective remote patient monitoring for cardiovascular conditions.
  • Provides clear and actionable ECG data for clinicians.
  • User-friendly interface for both patients and healthcare providers.
  • Facilitates early detection of arrhythmias and improves patient outcomes.
  • Integrates seamlessly with existing clinical workflows.
  • Reduces the need for frequent in-person visits for routine monitoring.

Limitations

  • Initial setup and integration can be complex for some practices.
  • Potential for data overload for clinicians managing many patients.
  • Cost of the system and devices can be a barrier for smaller practices or patients.
  • Reliance on patient compliance for consistent data submission.
  • Some users report occasional connectivity issues with devices.
  • Limited interoperability with certain electronic health record (EHR) systems.

Based on reviews from: Physician reviews (various medical forums and journals), Healthcare IT publications, Tech reviewer analyses, Reddit discussions (r/medicine, r/cardiology), G2 reviews, Capterra reviews

Last updated: 2026-09-25

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate KardiaPro

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

AliveCor Newsroom
AliveCor Launches KardiaACCESS: A Medicare-Covered Program Built to Improve Blood Pressure, Diabetes, and Heart Health
AliveCor launched KardiaACCESS, a Medicare-covered program designed to enhance blood pressure, diabetes, and heart health. This program aims to expand access to remote patient monitoring for a broader patient population.
2026-09
AliveCor Newsroom
New Study Demonstrates AliveCor's KardiaMobile 6L Significantly Increases Arrhythmia Detection Beyond Traditional Ambulatory Monitoring
A new study highlights that AliveCor's KardiaMobile 6L significantly improves arrhythmia detection compared to conventional ambulatory monitoring methods. This suggests enhanced diagnostic capabilities for healthcare professionals.
2026-08
AliveCor Newsroom
AliveCor Announces FDA Clearance of New Cardiac Determinations for Kardia 12L ECG System, Bringing Total to 39
AliveCor received FDA clearance for five new cardiac determinations for its Kardia 12L ECG System, increasing the total to 39. This expands the diagnostic capabilities of the AI-powered, handheld 12-lead ECG system.
2026-01
AliveCor Newsroom
AliveCor Launches AI-Powered Kardia 12L in Europe: The World's First Handheld 12-Lead ECG with a Unique Single-Cable Design
AliveCor launched its AI-powered Kardia 12L ECG System in Europe after receiving CE Mark approval. This portable 12-lead ECG system, with a single-cable design, aims to improve access to high-quality cardiac care.
2026-04
Signify Research
Not Resting on its laurels: AliveCor throws the Diagnostic Cardiology market another curveball
AliveCor's Kardia 12L ECG System, recently FDA approved, has been granted new CPT Category III Codes by the AMA, effective January 2025. This development is expected to impact the diagnostic cardiology market.
2024-07
JMIR Cardio
Outcomes of a Remote Cardiac Rehabilitation Program for Patients Undergoing Atrial Fibrillation Ablation: Pilot Study
A pilot study investigated the outcomes of a remote cardiac rehabilitation program utilizing KardiaMobile 6L and KardiaPro for patients post-atrial fibrillation ablation. The study explored the integration of these devices for ECG review and storage within an EMR.
2023-12
Knobbe Martens
Developments in Patent Disputes Between Apple and Alivecor
Apple has filed a lawsuit against AliveCor, alleging that KardiaPro and other Kardia devices infringe on Apple's patents. This follows an earlier International Trade Commission ruling where AliveCor successfully argued Apple infringed on its ECG technology patents.
2022-12
PR Newswire
AliveCor Announces Series F Financing to Help Expand Offerings to Key Healthcare Industry Stakeholders
AliveCor secured Series F financing to expand its offerings, including KardiaPro for physicians, and subscription services like KardiaCare and KardiaComplete. This funding will support advancements in AliveCor's AI roadmap and innovations.
2022-08

Videos

Product demos, reviews, and walkthroughs for KardiaPro.

View all on YouTube

Frequently Asked Questions

KardiaPro leverages AI to analyze ECGs for potential arrhythmias, providing automated interpretations and flagging studies that may require further review. This AI-powered analysis aims to enhance the efficiency of ECG interpretation and support earlier detection of cardiac events.
KardiaPro is FDA-cleared, and AliveCor, its developer, adheres to HIPAA regulations for patient data privacy and security. The platform is designed to ensure the secure handling and transmission of sensitive patient information.
KardiaPro differentiates itself through its integration with KardiaMobile devices for personal ECG recording, its AI-driven interpretive algorithms, and its physician-facing platform for streamlined review and practice management. While other solutions exist, KardiaPro focuses on ease of use for both patients and providers, alongside its AI capabilities.
KardiaPro typically operates on a subscription model, with pricing that can vary based on the number of patients monitored and the specific features required by a practice. It's best to contact AliveCor directly for detailed pricing information tailored to your practice's needs.
While KardiaPro's AI is highly effective in detecting common arrhythmias like atrial fibrillation, it has limitations in diagnosing all cardiac conditions. Physicians should always use their clinical judgment and consider the patient's full medical history when interpreting KardiaPro's findings, especially in complex cases or specific patient populations where AI accuracy might vary.
KardiaPro offers integration capabilities with various EHR systems, allowing for the seamless transfer of ECG data and interpretations into patient charts. The specific integration process and workflow can vary depending on your EHR system, and AliveCor provides support for setting up these connections.
AliveCor provides comprehensive training and support for KardiaPro users, including educational resources, online tutorials, and direct customer support. This ensures that physicians and their staff can effectively utilize the platform and confidently interpret its AI-driven insights.

Compare KardiaPro

VS
KardiaPro vs EchoNext
Cardiology AI Adjacent · 65/100
KardiaPro is a remote patient monitoring platform that uses AI for arrhythmia detection and manages various patient data, including ECGs, blood pressure, and weight. EchoNext, on the other…
VS
KardiaPro vs Sleepiz One+
Cardiology AI Adjacent · 65/100
KardiaPro and Sleepiz One+ are adjacent competitors in the remote patient monitoring space, both offering FDA-cleared AI for health data analysis and CPT code reimbursement. KardiaPro focuses on…
VS
KardiaPro vs Cardiomo
Cardiology AI Direct · 85/100
KardiaPro and Cardiomo are direct competitors, both offering AI-powered platforms for remote cardiac monitoring and arrhythmia detection. While KardiaPro focuses on integrating with its suite of Kardia devices…
VS
KardiaPro vs PMcardio
Cardiology AI Direct · 85/100
KardiaPro and PMcardio are highly comparable as both are AI-powered platforms focused on ECG interpretation for cardiac conditions. KardiaPro offers a comprehensive remote monitoring portal integrating ECG, blood…

Related Tools

EchoMD AutoEF
Caption Health (formerly Bay Labs, now part of GE HealthCare)
Cardiology AI
EchoMD AutoEF is an FDA-cleared AI software that automates the selection of echocardiogram clips and calculates left ventricular ejection fraction (EF), enhancing efficiency and accuracy in cardiac assessments.
ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm
Anumana, Inc.
Cardiology AI
An AI algorithm for screening cardiac amyloidosis using standard 12-lead ECGs.
DEEPVESSEL Plaque
Keya Medical Technology Co., Ltd.
Cardiology AI
An AI software platform for coronary plaque analysis and quantification from CT angiography.
WatchMate Software
Anumana, Inc.
Cardiology AI
Anumana is an AI-driven health technology company from nference, developing and delivering ECG algorithms enabling early diagnosis and intervention.
syngo.CT Coronary Cockpit
Siemens Healthineers
Cardiology AI
syngo.CT Coronary Cockpit is an AI-powered software tool by Siemens Healthineers for efficient and accurate CT coronary angiography analysis.
HeartLung AI-CVD®
HeartLung Corporation
Cardiology AI
HeartLung AI-CVD® is an FDA-cleared AI-powered quantitative imaging tool that provides automated CT-derived measurements for assessing cardiovascular and multisystem risks opportunistically.

See all Cardiology AI tools →

More from AliveCor

AliveCor QT Service
AliveCor
Cardiology AI
A cloud-based Software as a Medical Device (SaMD) that provides instant, accurate QT and QTc interval measurements from AliveCor 6-Lead ECGs, enabling healthcare professionals to assess cardiac safety and inform medication prescribing decisions.
Varies by product and service, with subscription options available.
Corvair
AliveCor
Cardiology AI
Corvair by AliveCor is an FDA-cleared AI ECG analysis system that assists healthcare professionals in interpreting resting diagnostic ECGs with 35 cardiac determinations.
Impala
AliveCor
Cardiology AI
AliveCor's 'Impala' (FDA K232035) is a portable, AI-powered 12-Lead ECG device for healthcare professionals, not a physician directory tool. AliveCor specializes in cardiac monitoring solutions.
Contact for pricing
Kardia 12L and KAI 12L
AliveCor
Cardiology AI
Kardia 12L and KAI 12L offer a portable, AI-powered 12-lead ECG system for healthcare professionals, enabling rapid and accurate detection of numerous cardiac conditions with a simplified setup.
$2295

View company profile →

Suggest an Edit → | Report an issue | Last Verified: 2026-06-23 | First Added: 2026-06-23

Investors who backed KardiaPro

Funded through the company that built this tool.

Qualcomm Ventures Healthcare
Corporate VC T3
San Diego, United States
$1M-$5M
Qualcomm Ventures Healthcare is the healthcare-focused activity of Qualcomm Ventures, the strategic investment arm of Qualcomm. The fund’s healthcare thesis follows directly…
Digital Health Medical Devices / MedTech
Mayo Clinic Ventures
Corporate VC T3
Rochester, United States
$250k-$1M
Mayo Clinic Ventures is the commercialization and venture arm of Mayo Clinic, investing in companies that align with the institution’s clinical and…
AI/ML in Healthcare Biotech
AI Tool Finder
AI-powered search. Results may not be comprehensive.